Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients.
Jeffrey E JohnsonPaula D StrassleGuilherme C de OliveiraChris B AgalaPhilip SpanheimerKristalyn GallagherDavid OllilaHyman MussStephanie M Downs-CannerPublished in: Breast cancer research and treatment (2021)
Age is the primary determinant of the likelihood of a woman to receive optimal adjuvant therapies in high-risk early-stage breast cancer. Patients who did not receive optimal therapy had significantly diminished survival.
Keyphrases
- early stage
- positive breast cancer
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- minimally invasive
- ejection fraction
- prognostic factors
- coronary artery bypass
- coronary artery disease
- sentinel lymph node
- patient reported outcomes
- neoadjuvant chemotherapy
- radiation therapy
- percutaneous coronary intervention
- acute coronary syndrome
- bone marrow
- patient reported
- atrial fibrillation
- smoking cessation
- free survival